
Medtronic wins CE mark for next-gen Micra leadless pacemakers
Medtronic (NYSE: MDT)+
announced today that it received CE mark approval for its next-generation Micra AV2 and Micra VR2 miniature, leadless pacemakers.

Medtronic (NYSE: MDT)+
announced today that it received CE mark approval for its next-generation Micra AV2 and Micra VR2 miniature, leadless pacemakers.

Imagine electrostatic materials that function even with extremely weak ultrasound, heralding the era of permanent implantable electronic devices in biomedicine.

A research team from Odense University Hospital and the University of Southern Denmark has developed an innovative screening test. With a blood sample from the expectant mother, they can scrutinize all the genes in the fetus.

Siemens Healthineers announced today that the FDA cleared its Magnetom Cima.X 3 Tesla (3T) magnetic resonance imaging whole-body scanner.

iRhythm Technologies (Nasdaq: IRTC)+
announced today that it received CE mark for its Zio system and its supporting Zeus AI algorithm.

EndoSound announced today that it received FDA 510(k) clearance for its EndoSound Vision System (EVS).

FDA clearance supported by highly compelling clinical study results demonstrating 93% of subjects treated arms were “improved” or “very much improved” in appearance, following treatment utilizing SUPERB™

Swallowing the device before a meal could create a sense of fullness, tricking the brain into thinking it’s time to stop eating.

Thanks to new technology, a tiny capsule camera can examine your intestines while you get on with your work or walk your dog. Compared with the alternatives, patients experience virtually no discomfort at all.

Johnson & Johnson MedTech unit Acclarent announced that it won a new FDA clearance for its Aera Eustachian tube balloon dilation system.